Atlas Trials

Safety and Immunogenicity of Recombinant Zoster Vaccine for Transplant Recipients

Clinical trial NCT06262776 · RECRUITING

Trial details

NCT number
NCT06262776
Sponsor
Central Adelaide Local Health Network Incorporated
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
ImmunosuppressionVaccine Response Impaired
Start date
2024-03-20
Primary completion
2026-12-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.